{"id":"brovanexine","rwe":[],"tags":[{"label":"brovanexine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"bronquimucil","offLabel":[],"synonyms":["brovanexine","brovanexine monohydrochloride","bronquimucil","brovanexine hydrochloride","brovanexine HCl","BR-222"],"timeline":[],"brandName":"Bronquimucil","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"brovanexine","explanation":"Unfortunately, we don't know exactly how Bronquimucil (BROVANEXINE) works, but it's thought to target a specific area in the body to produce its effects. More research is needed to understand how it interacts with the body's cells and systems. This lack of information makes it difficult to predict how the drug will affect different people.","oneSentence":"Bronquimucil (BROVANEXINE) is a small molecule drug that works by interacting with a specific target in the body, but its exact mechanism of action is unknown.","technicalDetail":"As a small molecule drug of the brovanexine class, Bronquimucil (BROVANEXINE) is likely to interact with a specific protein or receptor in the body, but the exact details of this interaction are not yet understood."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/410","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BROVANEXINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:03:23.903736","biosimilars":[],"competitors":[],"genericName":"brovanexine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004296","UNII":"Y00SD533IW","CHEBI":"CHEBI:135832","INN_ID":"3527","RXNORM":"19791","UMLSCUI":"C0054152","ChEMBL_ID":"CHEMBL2105477","KEGG_DRUG":"D07544","DRUGBANK_ID":"DB14720","PUBCHEM_CID":"162137","SECONDARY_CAS_RN":"54340-60-2","MESH_SUPPLEMENTAL_RECORD_UI":"C012222"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":8,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bronquimucil (BROVANEXINE) is a small molecule drug of the brovanexine class, but specific details about its development, approval, and commercial status are not available. Its target and mechanism of action are unknown. As a result, there is limited information available about its approved indications, half-life, bioavailability, and generic manufacturers. Further research is needed to understand the safety and efficacy of this drug. Its commercial status, including whether it is patented or off-patent, is also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}